09:30 – 10:00
Scientific Focus
ScientificProgramme
Scientific agenda overview for 29 January 2027 — a full day of evidence-based discussion across the acute leukemia treatment pathway.
29 January 2027
Morning Sessions
10:00 – 10:45
New AML classification
Disease biology, genetics, and how treatment is affected
10:45 – 11:45
Frontline therapies:
Selecting the right treatment for the right patient
- 10:45 – 11:05 Frontline treatment in secondary AML
- 11:05 – 11:25 Frontline treatment in elderly unfit population
- 11:25 – 11:45 Frontline therapy in younger fit patients
11:45 – 12:00
Morning coffee and Networking Break
12:00 – 12:45
Treatment in the relapsed refractory setting
Chemotherapy vs targeted treatment
12:45 – 13:30
The role of stem cell transplant in standard risk AML
- One speaker favours BMT (20 mins)
- One speaker favours non BMT (20 mins)
13:30 – 14:15
Lunch Break
29 January 2027
Afternoon Sessions
14:15 – 15:00
The role of MRD in AML treatment
15:00 – 15:45
Palliative care and emotional support:
Quality of life from diagnosis onward
15:45 – 16:45
Case studies, open Q&A session, and closing remarks.
29 January 2027
Gala Dinner
19:00
ALIF Gala Dinner
An evening of connection, conversation and collaboration.